Growth Accelerated by Rising Demand from Biomedical Research and Clinical Diagnostics

 


Chemiluminescence imaging is widely used technique for the detection of biomolecules. The technique offers advantages such as high sensitivity, minimal sample requirement and less incubation time. Chemiluminescence assays find wide application in various research areas such as oncology research, infectious disease research and reproductive health among others. Moreover, clinical diagnostics of conditions like cancer, liver disorders also rely on chemiluminescence technique for detection of biomarkers. Growing incidence of chronic diseases is propelling the demand for clinical diagnostic testing, thus favoring the growth of chemiluminescence imaging market.

The global Chemiluminescence Imaging Market is estimated to be valued at US$ 13.2 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Rising demand from biomedical research and clinical diagnostics is a major trend fueling the growth of chemiluminescence imaging market. Due to increasing incidence of chronic diseases, there is significant focus on development of novel drugs and identification of disease biomarkers. Chemiluminescence technique is commonly employed in various studies related to oncology, genomics and proteomics research due to its high sensitivity. Moreover, growing volume of clinical diagnostic tests performed for screening and evaluation of diseases is propelling the adoption of chemiluminescence imaging systems by diagnostic laboratories and hospitals. As per estimates, over 7 billion clinical diagnostic tests are performed annually worldwide. Rise in disease prevalence in developing nations is expected to further augment the demand.

Segment Analysis

The Global chemiluminescence imaging market Size is dominated by instruments as it accounts for the largest revenue share of more than 60%. Chemiluminescence imager instruments are extensively used for biomedical research and diagnostic applications such as protein assays, nucleic acid detection, enzyme-linked immunosorbent assays (ELISA), western blotting, and Southern, northern and slot blotting. Instruments provide high sensitivity, wide linear dynamic range, high resolution and ability to visualize multiple signals simultaneously which makes it a preferred choice for various chemiluminescence detection applications.

Key Takeaways

The global chemiluminescence imaging market is expected to witness high growth over the forecast period owing to factors such as rising R&D expenditures in pharma and biotech industries, increasing government support for clinical and pre-clinical research, and growing demand for highly sensitive diagnostic and research tools. The global chemiluminescence imaging market is estimated to be valued at US$ 13.2 billion in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030.

Regional analysis:

North America dominates the global chemiluminescence imaging market and is expected to maintain its dominance during the forecast period. High adoption of advanced imaging systems in research and clinical settings as well as presence of major players drives the growth of the market in this region. Asia Pacific is projected to witness highest growth rate over the forecast period attributed to factors such as growing research funding, increasing healthcare expenditure, rising incidences of chronic diseases and improving healthcare infrastructure in emerging economies of the region.

Key players related content: Key players operating in the chemiluminescence imaging market are Azure Biosystems, Inc.,Berthold Technologies GmbH & Co. KG,Carestream Health, Inc.,GE Healthcare,LI-COR Biosciences,PerkinElmer, Inc.,Syngene International Limited,Tecan Trading AG,Thermo Fisher Scientific Inc.,UVItec Limited. These companies are focusing on new product launches, expansions, agreements and partnerships to strengthen their presence in the global market. For instance, in 2021, Azure Biosystems introduced the NioFlux CL instrument for high performance chemiluminescence imaging.

Get More Insights On This Topic: https://www.newsstatix.com/chemiluminescence-imaging-market-size-share-analysis-2023-2030/

Comments

Post a Comment

Popular posts from this blog

Macrophage Marker Market Poised to Grow at a Robust Pace Due to Rising Demand in Medical Diagnostics

Image
  The macrophage marker market has witnessed significant growth in recent years owing to the growing applications of macrophage markers in medical diagnostics. Macrophage markers are proteins or cell surface receptors that are expressed by macrophages and are used to identify and study macrophages and their functions. Some of the key macrophage markers include CD14, CD68, CD163, CD206, and LAMP-3. These markers play a vital role in studying the functions of macrophages in various diseases like cancer, inflammatory disorders, and infectious diseases. The global macrophage marker market is estimated to be valued at US$ 295.15 million in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period of 2024-2030. The growing prevalence of various chronic and infectious diseases and increase in R&D spending for drug discovery are some of the key factors driving the demand for macrophage markers in recent years. Macrophage markers help in evaluating disease progression, d...
Read more

The Global Boat Accumulator Market Growth Is Accelerated By Increasing Consumer Spending

Image
  Boat accumulators or batteries are sealed lead acid batteries that provide starting power and deep cycle power for boats. They are essential for powering marine electrical systems, motors, navigation lights, bilge pumps and other onboard appliances. The growing marine tourism and recreational boating activities have increased the demand for boats and yachts over the years. This has propelled the boat accumulator market. The global Boat Accumulator Market is estimated to be valued at US$ 266.66 Mn in 2023 and is expected to exhibit a CAGR of 2.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing consumer spending on recreational boating activities has been a major driver for the boat accumulator market over the past decade. The number of recreational boats sold globally has increased steadily with the rise in disposable incomes and leisure time among consumers. Countries like the United S...
Read more